Ex-Harkat chief passes away after prolonged illness

Arshid was bed-ridden since 2002. “But despite his ill-health he contributed in whatever way he could to the movement. A week before his death, he told a group of friends who had visited him that his faith in the movement remains unshaken,” Arshid’s family said.

A former chief commander of erstwhile militant outfit, Harkat-ul-Mujahideen, has passed away in Srinagar.

Arshid Ahmed Kondji, 46, died of renal failure on Wednesday, 4 April, at SKIMS, Soura, after a prolonged illness.

Arshid, a post-graduate in Islamic Studies from the University of Kashmir, had remained bed-ridden for around 15 years, after he was severely tortured in custody by the Special Operations Group of police in 1997.

Despite being physically challenged, Arshid, a resident of Nawa Kadal in downtown, Srinagar, joined Hizbullah militant outfit in 1991. Later, in 1993, he joined Harkat-ul-Mujahideen and became its chief commander, reports said.

“He was arrested by the SOG in 1997 and brutally tortured by a notorious SP from Jammu. As a result of the inhuman torture, Arshid’s both kidneys were damaged,” reports quoted his family and friends as saying.

Given his ailing health, his PSA was quashed and he was released from Srinagar Central Jail in 1998, the family said.

Arshid was later issued a passport and he travelled to Pakistan for surgery of his damaged kidneys. “He stayed for some months in Pakistan, where he was treated for free because of his contribution to the movement. But the doctors there had told him that he will survive for only 10-15 years as his renal system had suffered massive damage,” the family said.

Arshid was bed-ridden since 2002. “But despite his ill-health he contributed in whatever way he could to the movement. A week before his death, he told a group of friends who had visited him that his faith in the movement remains unshaken,” Arshid’s family said.

  • author's avatar

    By: KN Web Desk

    No biography available at this time

  • author's avatar

  • 378
    Shares
  • 378
    Shares

Leave a Reply

Your email address will not be published.